Acquired neuro-secretory defect in growth hormone secretion due to Imatinib mesylate and the efficacy of growth hormone therapy in children with chronic myeloid leukemia-Reference-Cited by-同舟云学术

Acquired neuro-secretory defect in growth hormone secretion due to Imatinib mesylate and the efficacy of growth hormone therapy in children with chronic myeloid leukemia

Published:2019-11-20 Issue:2 Volume:37 Page:99-108
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Walia Rama¹,Aggarwal Anuradha¹,Bhansali Anil¹,Aggarwal Anshita¹,Varma Neelam²,Sachdeva Naresh¹,Khandelwal Niranjan³,Bansal Deepak⁴^ORCID

Affiliation:

1. Department of Endocrinology, PGIMER Chandigarh, Chandigarh, India;

2. Department of Pathology, PGIMER Chandigarh, Chandigarh, India;

3. Department of Radio-Diagnosis, PGIMER Chandigarh, Chandigarh, India;

4. Department of Pediatrics (Hemat-Oncology Unit), PGIMER Chandigarh, Chandigarh, India

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/08880018.2019.1689320

Reference26 articles.

1. Epidemiologic studies in a population-based childhood cancer registry in Northeast Hungary

2. Clinicopathologic characteristics of leukemia in Japanese children and young adults

3. Distinct Impact of Imatinib on Growth at Prepubertal and Pubertal Ages of Children with Chronic Myeloid Leukemia

4. Imatinib has adverse effect on growth in children with chronic myeloid leukemia

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Tyrosine Kinase Inhibitors (TKIs) on Growth in Children and Adolescents with Chronic Myeloid Leukemia: A Systematic Review;Current Pharmaceutical Design;2024-09

2. BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach;Current Oncology Reports;2024-02-10

3. Treatment and follow‐up of children with chronic myeloid leukaemia in chronic phase (CML‐CP) in the tyrosine kinase inhibitor (TKI) era—Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort;British Journal of Haematology;2023-12-14

4. Thyroid dysfunction during treatment with systemic antineoplastic therapy for childhood cancer: A systematic review;Critical Reviews in Oncology/Hematology;2023-04

5. Effect of Imatinib Mesylate on Growth in Pediatric Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis;Journal of Pediatric Hematology/Oncology;2023-03-17